Shimadzu Completes $711m TESCAN Acquisition

Shimadzu has completed the $711m (¥115.2 billion) acquisition of Czech-based electron microscopy specialist TESCAN, adding a full suite of surface analysis and imaging instrumentation to its analytical portfolio. Announced on 10 July 2026, the deal closes a transaction originally disclosed in December 2025 and positions Shimadzu to offer end-to-end analytical solutions across semiconductors, life sciences and materials, three of the most closely watched growth pockets in analytical instrumentation.

Founded in 1991 and headquartered in Brno, TESCAN employs 898 people and has sold more than 4,000 systems across 80 countries. Its portfolio spans scanning electron microscopes (SEM), focused ion beam SEM (FIB-SEM) systems, transmission electron microscopes (TEM), X-ray micro-CT and laser processing systems, giving Shimadzu direct entry into the electron microscopy segment for the first time at commercial scale. Shimadzu framed the strategic rationale around end-to-end solutions: pairing compositional and physical property data from its established chromatography, mass spectrometry and materials testing lines with the surface observation data now available through TESCAN’s electron microscopy platform.

The regional footprint of the two companies is also broadly complementary. Shimadzu holds a dominant position across Asia while TESCAN is more strongly established in Europe and North America, giving both product lines wider distribution reach without significant channel overlap. TESCAN CEO Jean-Charles Chen continues in role, with Haruhiko Miyagawa appointed as Chairman as part of the closing arrangements. TESCAN will be included in Shimadzu’s consolidated balance sheet from Q2 of the fiscal year ending March 2027 and the consolidated income statement from Q3.

The commercial signal is Shimadzu executing on a broader analytical instrumentation consolidation thesis at the moment competitors are doing the same. With Merck KGaA’s $11.3bn Bio-Techne acquisition and Thermo Fisher’s Clario deal both landing in recent months, the analytical instrumentation market is being reshaped around cross-modality, end-to-end platforms rather than best-in-class single-technology positioning. Bruker and JEOL are the immediate competitive watch names in electron microscopy specifically.

For the latest updates and in-depth insights into the world of Service Engineering, including breakthrough treatments, industry trends, and regulatory news, contact Bilal Hussain today!